Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update - Cov-ID Project

1 May 2020 09:00

RNS Number : 6383L
Catenae Innovation PLC
01 May 2020
 

1 May 2020

Catenae Innovation PLC

("Catenae", or the "Company")

 

Update - Cov-ID Project

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, reports that, further to the announcement of 17 April 2020, the Company has built an operational prototype for the development of "Cov-ID", a GDPR compliant identity documentation exchange system to record an individual's Covid-19 test status through a mobile app that is intended to be marketed to businesses and organisations. The Company's existing technology has been further developed and has been repurposed and enhanced to develop the operational prototype.

 

The Cov-ID project is a joint initiative by a consortium of companies led by the Z/Yen Group. The platform is GDPR compliant and provides a secure documentation exchange where individuals can store a record of their Covid-19 test status. Catenae and the other consortium members (Z/Yen Group, fm2x and SI Units) are in the process of negotiating the proposed commercial terms of the Cov-ID product.

 

It is expected that the project will enter the trialling and finalisation phase of its development by 18 May 2020.

 

Although the prototype Cov-ID app has been developed, there is no guarantee that it will be finalised nor enter the commercialisation stage, nor that in the event that it is commercialised, that any sales will be generated.

 

A further announcement will be made in due course.

 

Guy Meyer, Interim Chief Executive Officer, commented: "We are pleased to have completed the first phase of the technical development of the Cov-ID software and to have an operational prototype that is ready to be tested. The software can play a role in mitigating risk to business continuity and building resilience for organisations.

"We are on track with the project and look forward to keeping the market updated with further progress."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0) 191 580 8545

Guy Meyer, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44 (0)20 7213 0880

Liam Murray

Jo Turner

Brandon Hill Capital Limited Broker

Andy Gutmann

+44 (0) 20 3463 5000

+44 (0)78796 8313

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins

Annabel Atkins

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUAVBRRNUVRRR
Date   Source Headline
30th Mar 20213:42 pmRNSDirector dealings
30th Mar 20217:00 amRNSUK Government 'COVID-Status Certification Review'
29th Mar 20217:00 amRNSAnnual Report and Accounts, Trading Update
16th Mar 20211:19 pmRNSExercise of Warrant
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:13 pmRNSHolding(s) in Company
26th Feb 202111:00 amRNSCorrection re Placing, Conversions, Warrants
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSDigital Identity Policy Consultation
29th Jan 20217:00 amRNSPilot Agreement
27th Jan 20217:00 amRNSPlacing, Conversions, Warrants & Business Update
11th Jan 20212:06 pmRNSSecond Price Monitoring Extn
11th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Dec 202011:39 amRNSHolding(s) in Company
15th Dec 20203:41 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBusiness Update
9th Dec 20209:27 amRNSHolding(s) in Company
5th Nov 202012:30 pmRNSUpdate on Afrik-ID
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
2nd Nov 202011:06 amRNSSecond Price Monitoring Extn
2nd Nov 202011:00 amRNSPrice Monitoring Extension
16th Oct 20208:43 amRNSIssue of Warrants
16th Oct 20207:00 amRNSJoint Venture with Blackhive Africa Medical
25th Sep 202012:26 pmRNSResult of AGM
4th Sep 202012:50 pmRNSPosting of Notice of AGM
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
25th Aug 20207:00 amRNSBusiness Update
24th Aug 20207:00 amRNSCreditor Share Conversion and Notice of AGM
19th Aug 20202:32 pmRNSHolding(s) in Company
23rd Jul 202011:05 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSChange of Director Role and Grant of Options
17th Jul 20207:00 amRNSTransfer and Exercise of Warrants
9th Jul 202011:05 amRNSSecond Price Monitoring Extn
9th Jul 202011:00 amRNSPrice Monitoring Extension
8th Jul 20209:14 amRNSHolding(s) in Company
6th Jul 20202:06 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 20201:15 pmRNSExercise of Warrants
6th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20207:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSCompletion of New Product - Onsite ID
3rd Jul 20207:00 amRNSCommercial Pilot Agreement with Afrik-ID
2nd Jul 20208:01 amRNSHolding(s) in Company
1st Jul 20203:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.